238 related articles for article (PubMed ID: 27859142)
1. Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer.
Yang H; Brand JS; Fang F; Chiesa F; Johansson AL; Hall P; Czene K
Int J Cancer; 2017 Feb; 140(4):841-852. PubMed ID: 27859142
[TBL] [Abstract][Full Text] [Related]
2. The Pathologic Finding of Combined Lobular Carcinoma
Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
[TBL] [Abstract][Full Text] [Related]
3. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
4. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.
Sackey H; Hui M; Czene K; Verkooijen H; Edgren G; Frisell J; Hartman M
Breast Cancer Res; 2016 Oct; 18(1):105. PubMed ID: 27756431
[TBL] [Abstract][Full Text] [Related]
5. Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis: A Nationwide Matched Cohort Study in Sweden.
Lu D; Andersson TM; Fall K; Hultman CM; Czene K; Valdimarsdóttir U; Fang F
JAMA Oncol; 2016 Sep; 2(9):1188-96. PubMed ID: 27124325
[TBL] [Abstract][Full Text] [Related]
6. Second cancers following in situ carcinoma of the breast.
Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
[TBL] [Abstract][Full Text] [Related]
7. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
Hemminki K; Granström C
Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
[TBL] [Abstract][Full Text] [Related]
8. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
9. Correlations between state anxiety and quality of life in metastatic breast cancer patients.
Dragomir BI; Fodoreanu L
Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):610-5. PubMed ID: 24502024
[TBL] [Abstract][Full Text] [Related]
10. Changes in caseness of anxiety and depression in breast cancer patients during the first year following surgery: patterns of transiency and severity of the distress response.
Saboonchi F; Petersson LM; Wennman-Larsen A; Alexanderson K; Brännström R; Vaez M
Eur J Oncol Nurs; 2014 Dec; 18(6):598-604. PubMed ID: 24997517
[TBL] [Abstract][Full Text] [Related]
11. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
[TBL] [Abstract][Full Text] [Related]
12. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
13. Contralateral breast cancer: incidence according to ductal or lobular phenotype of the primary.
Langlands F; White J; Kearins O; Cheung S; Burns R; Horgan K; Sharma N; Dodwell D
Clin Radiol; 2016 Feb; 71(2):159-63. PubMed ID: 26703116
[TBL] [Abstract][Full Text] [Related]
14. Trends in incidence and management of lobular carcinoma in situ: a population-based analysis.
Portschy PR; Marmor S; Nzara R; Virnig BA; Tuttle TM
Ann Surg Oncol; 2013 Oct; 20(10):3240-6. PubMed ID: 23846782
[TBL] [Abstract][Full Text] [Related]
15. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M
J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145
[TBL] [Abstract][Full Text] [Related]
16. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
Di Meglio A; Freedman RA; Lin NU; Barry WT; Metzger-Filho O; Keating NL; King TA; Sertoli MR; Boccardo F; Winer EP; Vaz-Luis I
Breast Cancer Res Treat; 2016 Jun; 157(3):587-96. PubMed ID: 27271765
[TBL] [Abstract][Full Text] [Related]
17. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.
Kuo WH; Yen AM; Lee PH; Hou MF; Chen SC; Chen KM; Chen TH; Chang KJ
Breast Cancer Res Treat; 2006 Sep; 99(2):221-8. PubMed ID: 16544057
[TBL] [Abstract][Full Text] [Related]
19. Invasive breast cancer following ductal and lobular carcinoma in situ of the breast.
Levi F; Randimbison L; Te VC; La Vecchia C
Int J Cancer; 2005 Sep; 116(5):820-3. PubMed ID: 15838829
[TBL] [Abstract][Full Text] [Related]
20. Experience and predictors of symptoms, distress and health-related quality of life over time in postmenopausal women with recurrent breast cancer.
Kenne Sarenmalm E; Ohlén J; Odén A; Gaston-Johansson F
Psychooncology; 2008 May; 17(5):497-505. PubMed ID: 17886259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]